Voir la vidéoWatch the full video
100
100

Management ownership 100%

1
1

Turnover billion €

5
5

World Top 5

6000
6000

Headcount

News
Delpharm continues its growth in Europe with the acquisition of state-of-the-art drug production facilities in the Netherlands, from Astellas.

World-leading CDMO Delpharm expands its pharmaceutical network with the acquisition from Astellas of the Meppel pharmaceutical manufacturing facility.

Prefilled syringes
With Delpharm Leiden development center and Tours experts, we can support you in the development and manufacture of prefilled syringes. We have the capacity to produce between 25 and 30 million syringes a year in sizes ranging from 1ml to 50ml.
Regulatory affairs
A full team dedicated to support you in the long term or for emergency needs.
Read more...

Customer references

Zoetis
Sanionia
Aurobindo
Genfit
Mylan
Eisai
Urgo
Meda
Boehringer Indelheim
Bracco
Servier
Biocodex
LFB
HRA Pharma
Zentiva
Sanofi
Takeda
GlaxoSmithKline
Aguettant
Teva
Daiichi-Sankyo
Biogaran
Novartis
OM Pharma
Merck
Bayer
Cooper
Sandoz